← Leaderboards
Charles B Nemeroff
Emory University
$22,679,135
Attributed
$23,529,292
Total exposure
31
Grants
22
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$51,076,659 · 34
By mechanism
P50$28,825,732 · 9
R01$14,974,955 · 6
U19$4,182,419 · 1
M01$2,730,548 · 7
P51$363,005 · 11
Top collaborators
- Ihsan M Salloum3 shared
Most similar at Emory University
Same institution · by research overlap
- Benjamin Michael Hampstead$24,340,223
- Michael J. Mustari$17,735,510
- Andrew H Miller$19,656,811
- Kelly Rowe Bijanki$4,967,965
- Viola Vaccarino Vaccarino$32,669,670
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectGene ExpressionEarly ExperienceStressMajor DepressionNeurobiologyChild AbuseResponseMedicalFemaleTraumaCohortMeasurementUniversitiesBrainSamplingEpigenetic ProcessAntidepressantsExhibitsBiological MarkersBiologicalPost-Traumatic Stress DisordersMental Disorders
Grant awards (96)
Prediction of Alcohol Use Disorder and PTSD After Trauma in Adolescents$861,473
R01 · FY2025 · AA · contact PI
1/3 Understanding PTSD through Postmortem Targeted Brain Multi-omics$788,781
R01 · FY2025 · MH · contact PI
Prediction of Alcohol Use Disorder and PTSD After Trauma in Adolescents$859,337
R01 · FY2024 · AA · contact PI
Prediction of Alcohol Use Disorder and PTSD After Trauma in Adolescents$854,230
R01 · FY2023 · AA · contact PI
Prediction of Alcohol Use Disorder and PTSD After Trauma in Adolescents$947,876
R01 · FY2022 · AA · contact PI
1/3 Understanding PTSD through Postmortem Targeted Brain Multi-omics$543,615
R01 · FY2022 · MH · contact PI
1/3 Understanding PTSD through Postmortem Targeted Brain Multi-omics$600,456
R01 · FY2021 · MH · contact PI
1/3 Understanding PTSD through Postmortem Targeted Brain Multi-omics$599,110
R01 · FY2020 · MH · contact PI
1/3 Understanding PTSD through Postmortem Targeted Brain Multi-omics$603,797
R01 · FY2019 · MH · contact PI
Stem Cell Therapy, Inflammation and Treatment Response inAlcoholism-Depression Comorbidity$326,449
R01 · FY2019 · AA
Stem Cell Therapy, Inflammation and Treatment Response inAlcoholism-Depression Comorbidity$683,479
R01 · FY2018 · AA
1/3 Understanding PTSD through Postmortem Targeted Brain Multi-omics$501,201
R01 · FY2018 · MH · contact PI
Stem Cell Therapy, Inflammation and Treatment Response inAlcoholism-Depression Comorbidity$690,386
R01 · FY2017 · AA
1 of 2 - Prospective Determination of Psychobiological Risk Factors for PTSD$350,962
R01 · FY2016 · MH · contact PI
1 of 2 - Prospective Determination of Psychobiological Risk Factors for PTSD$349,570
R01 · FY2015 · MH · contact PI
1 of 2 - Prospective Determination of Psychobiological Risk Factors for PTSD$350,450
R01 · FY2014 · MH · contact PI
1 of 2 - Prospective Determination of Psychobiological Risk Factors for PTSD$341,793
R01 · FY2013 · MH · contact PI
1 of 2 - Prospective Determination of Psychobiological Risk Factors for PTSD$401,675
R01 · FY2012 · MH · contact PI
COLLABORATIVE MOOD DISORDERS INITIATIVE$54,800
P51 · FY2009 · RR · contact PI
EARLY LIFE STRESS IN NON HUMAN PRIMATES AND HUMANS$54,800
P51 · FY2009 · RR · contact PI
Clinical Psychobiology$249,549
P50 · FY2008 · MH · contact PI
COLLABORATIVE MOOD DISORDERS INITIATIVE$35,600
P51 · FY2008 · RR · contact PI
EARLY LIFE STRESS IN NON HUMAN PRIMATES AND HUMANS$28,536
P51 · FY2008 · RR · contact PI
Emory Conte Center for the Neuroscience of Mental Disorders$2,237,831
P50 · FY2007 · MH · contact PI
Predictors of Antidepressant Treatment Response: The Emory CIDAR$1,866,130
P50 · FY2007 · MH · contact PI
Operations, Clinical Assessments and Adminstrative Core$990,190
P50 · FY2007 · MH · contact PI
Neurotensin an endogenous neuroleptic-like peptide$403,802
R01 · FY2007 · MH · contact PI
Clinical Psychobiology$260,883
P50 · FY2007 · MH · contact PI
Primary Research Project: Functional MRI$238,808
P50 · FY2007 · MH · contact PI
Research Methods Core$234,788
P50 · FY2007 · MH · contact PI
Secondary Research Project: Monoamine Transporter Occupancy$216,907
P50 · FY2007 · MH · contact PI
Secondary Research Project: Genetics$139,581
P50 · FY2007 · MH · contact PI
Emory Conte Center for the Neuroscience of Mental Disorders$70,608
P50 · FY2007 · MH · contact PI
Special Scientific Procedures: Statistical Modeling Core$45,856
P50 · FY2007 · MH · contact PI
EMORY CONTE CENTER FOR THE NEUROSCIENCE OF MENTAL DISORDERS CLINICAL PSYCHOBIOL$34,519
M01 · FY2007 · RR · contact PI
EARLY LIFE STRESS IN NON HUMAN PRIMATES AND HUMANS$31,598
P51 · FY2007 · RR · contact PI
COLLABORATIVE MOOD DISORDERS INITIATIVE$15,799
P51 · FY2007 · RR · contact PI
Emory Conte Center for Neuroscience of Mental Disorders$2,212,925
P50 · FY2006 · MH · contact PI
Predictors of Antidepressant Treatment Response: The Emory CIDAR$1,933,631
P50 · FY2006 · MH · contact PI
Emory-GSK-NIMH Collaborative Mood Disorders Initiative$1,128,476
U19 · FY2006 · MH · contact PI
Operations, Clinical Assessments and Adminstrative Core$1,015,522
P50 · FY2006 · MH · contact PI
Neurotensin an endogenous neuroleptic-like peptide$398,796
R01 · FY2006 · MH · contact PI
Research Methods Core$254,682
P50 · FY2006 · MH · contact PI
Primary Research Project: Functional MRI$251,144
P50 · FY2006 · MH · contact PI
Clinical Psychobiology$229,297
P50 · FY2006 · MH · contact PI
Secondary Research Project: Monoamine Transporter Occupancy$225,748
P50 · FY2006 · MH · contact PI
Secondary Research Project: Genetics$140,648
P50 · FY2006 · MH · contact PI
Special Scientific Procedures: Statistical Modeling Core$45,887
P50 · FY2006 · MH · contact PI
PSYCHOBIOLOGY OF EARLY-LIFE TRAUMA$42,393
M01 · FY2006 · RR · contact PI
EARLY LIFE STRESS IN NON HUMAN PRIMATES AND HUMANS$40,116
P51 · FY2006 · RR · contact PI
COLLABORATIVE MOOD DISORDERS INITIATIVE$40,116
P51 · FY2006 · RR · contact PI
Emory Conte Center for Neuroscience of Mental Disorders$18,078
P50 · FY2006 · MH · contact PI
EARLY ADVERSE LIFE EVENTS AND MAJOR DEPRESSION$1,735
M01 · FY2006 · RR · contact PI
Emory Conte Center for Neuroscience of Mental Disorders$2,209,799
P50 · FY2005 · MH
Emory-GSK-NIMH Collaborative Mood Disorders Initiative$1,499,366
U19 · FY2005 · MH
Clinical Psychobiology$229,199
P50 · FY2005 · MH
EARLY LIFE STRESS IN NON HUMAN PRIMATES AND HUMANS$30,784
P51 · FY2005 · RR
COLLABORATIVE MOOD DISORDERS INITIATIVE$15,428
P51 · FY2005 · RR
EMORY CONTE CENTER FOR THE NEUROSCIENCE OF MENTAL DISORDERS$15,428
P51 · FY2005 · RR
Emory Conte Center for Neuroscience of Mental Disorders$1,444,307
P50 · FY2004 · MH
Emory-GSK-NIMH Collaborative Mood Disorders Initiative$805,849
U19 · FY2004 · MH
PSYCHOBIOLOGY OF CORTICOTROPIN-RELEASING FACTOR$380,000
R01 · FY2004 · MH
NEUROTENSIN, AN ENDOGENOUS NEUROLEPTIC-LIKE PEPTIDE$342,000
R01 · FY2004 · MH
Clinical Psychobiology$228,247
P50 · FY2004 · MH
Does Fluoxetine Reverse the Effects of Early Life Stress on the CNS CRF System$8,568
M01 · FY2004 · RR
Early Adverse Life Events and Major Depression$5,712
M01 · FY2004 · RR
EMORY CONTE CENTER FOR NEUROSCIENCE OF MENTAL DISORDERS$2,881,761
P50 · FY2003 · MH
Emory-GSK-NIMH Collaborative Mood Disorders Initiative$748,728
U19 · FY2003 · MH
PSYCHOBIOLOGY OF CORTICOTROPIN-RELEASING FACTOR$380,000
R01 · FY2003 · MH
NEUROTENSIN, AN ENDOGENOUS NEUROLEPTIC-LIKE PEPTIDE$342,000
R01 · FY2003 · MH
EMORY CONTE CENTER FOR NEUROSCIENCE OF MENTAL DISORDERS$2,845,672
P50 · FY2002 · MH
PSYCHOBIOLOGY OF CORTICOTROPIN-RELEASING FACTOR$380,000
R01 · FY2002 · MH
NEUROTENSIN, AN ENDOGENOUS NEUROLEPTIC-LIKE PEPTIDE$342,000
R01 · FY2002 · MH
EXAGGERATED PLATELET REACTIVITY IN MAJOR DEPRESSION$293,069
M01 · FY2002 · RR
PAROXETINE--TREATMENT OF EXAGGERATED PLATELET REACTIVITY WITH MAJOR DEPRESSION$293,069
M01 · FY2002 · RR
PAROXETINE--TREATMENT OF EXAGGERATED PLATELET REACTIVITY WITH MAJOR DEPRESSION$293,069
M01 · FY2002 · RR
EARLY ADVERSE LIFE EVENTS AND MAJOR DEPRESSION$293,069
M01 · FY2002 · RR
EARLY ADVERSE LIFE EVENTS AND MAJOR DEPRESSION$293,069
M01 · FY2002 · RR
EXAGGERATED PLATELET REACTIVITY IN MAJOR DEPRESSION$293,069
M01 · FY2002 · RR
FLUOXETINE IN CHILD ABUSE--PSYCHOLOGICAL/ENDOCRINE DIS$0
M01 · FY2002 · RR
HPA axis studies in women abused as children$0
P50 · FY2002 · MH
FLUOXETINE IN CHILD ABUSE--PSYCHOLOGICAL/ENDOCRINE DIS$0
M01 · FY2002 · RR
EMORY CONTE CENTER FOR NEUROSCIENCE OF MENTAL DISORDERS$2,769,760
P50 · FY2001 · MH
PSYCHOBIOLOGY OF CORTICOTROPIN-RELEASING FACTOR$381,458
R01 · FY2001 · MH
NEUROTENSIN, AN ENDOGENOUS NEUROLEPTIC-LIKE PEPTIDE$342,188
R01 · FY2001 · MH
EXAGGERATED PLATELET REACTIVITY IN MAJOR DEPRESSION$293,069
M01 · FY2001 · RR
PAROXETINE--TREATMENT OF EXAGGERATED PLATELET REACTIVITY WITH MAJOR DEPRESSION$293,069
M01 · FY2001 · RR
EARLY ADVERSE LIFE EVENTS AND MAJOR DEPRESSION$293,069
M01 · FY2001 · RR
HPA axis studies in women abused as children$0
P50 · FY2001 · MH
FLUOXETINE IN CHILD ABUSE--PSYCHOLOGICAL/ENDOCRINE DIS$0
M01 · FY2001 · RR
EMORY CONTE CENTER FOR NEUROSCIENCE OF MENTAL DISORDERS$2,717,105
P50 · FY2000 · MH
NEUROTENSIN, AN ENDOGENOUS NEUROLEPTIC-LIKE PEPTIDE$339,570
R01 · FY2000 · MH
PSYCHOBIOLOGY OF CORTICOTROPIN-RELEASING FACTOR$288,501
R01 · FY2000 · MH
HPA axis studies in women abused as children$231,924
P50 · FY2000 · MH
HPA axis studies in women abused as children$231,924
P50 · FY2000 · MH
EMORY CONTE CENTER FOR NEUROSCIENCE OF MENTAL DISORDERS$157,341
P50 · FY2000 · MH